Jonathan Sheena sold $953k of NTRA
director, other at Natera, Inc.. 5,700 shares at an average of $167.25, traded Dec 18, 2024, filed Dec 20, 2024.
Score components
- +15RoleDirector
- +24Trade size$953k at market
- 0Share of holdings soldSold 2.2% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-030009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | SOpen-market sale Common Stock10b5-1 | -338 | $165.97 | $56k | 259,434 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stock10b5-1 | -1,825 | $167.25 | $305k | 257,609 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stock10b5-1 | -537 | $168.15 | $90k | 257,072 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -238 | $166.18 | $40k | 47,544 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -959 | $167.18 | $160k | 46,585 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -303 | $168.04 | $51k | 46,282 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -152 | $166.01 | $25k | 47,630 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Srockindirect: By Caraluna 2 Trust10b5-1 | -852 | $167.07 | $142k | 46,778 | Dec 20, 2024 |
| Dec 18, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -496 | $168.02 | $83k | 46,282 | Dec 20, 2024 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $526k 1,273 shares | -1% | |
| 40Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $1.2M 3,000 shares | -3% | |
| 55Moderate | Natera, Inc. | Jonathan Sheena director, other | $7.0M 18,064 shares | -100% | |
| 35Weak | Natera, Inc. | Jonathan Sheena director, other | $3.2M 9,150 shares | -4% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $35M 102,000 shares | -5% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $16M 50,000 shares | -2% | |
| 39Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $545k 1,698 shares | -2% | |
| 45Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $5.9M 18,160 shares | -14% | |
| 36Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $846k 5,079 shares | -3% | |
| 57Moderate | Natera, Inc. | Rowan E Chapman director | $459k 2,750 shares | -31% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.